Novel brain injury treatment tested in 1st human subject

June 17, 2022

An experimental brain injury medication conceived in laboratories at UT Health San Antonio was tested Tuesday, June 14, in the first human subject. If the drug, called AST-004, performs well in human studies, it will be an urgently needed and novel treatment for stroke and traumatic brain injury victims, including those with concussions.

Neuron concept art

Pheo Para Alliance recognizes UT Health San Antonio as rare disease Center of Excellence

June 15, 2022

Contact: Will Sansom, 210-567-2579, sansom@uthscsa.edu SAN ANTONIO (June 15, 2022) — Pheo Para Alliance, a patient advocacy organization dedicated to supporting those with pheochromocytoma (pheo) and paraganglioma (para), a rare neuroendocrine tumor, has designated The University of Texas Health Science Center at San Antonio (UT Health San Antonio) as a Pheo Para Center of Excellence. The […]

Photo of baby with cancer

Novel brain injury treatment tested in 1st human subject

June 15, 2022

Drug conceived at UT Health San Antonio was safe, effective in animal studies Contact: Will Sansom, 210-567-2579, sansom@uthscsa.edu SAN ANTONIO, TEXAS, AND GROTON, CONN. (Wednesday, June 15, 2022) — An experimental brain injury medication conceived in laboratories at The University of Texas Health Science Center at San Antonio (UT Health San Antonio) was tested Tuesday, […]

Neuron concept art

$10 million from Bexar County to assist School of Public Health development

June 9, 2022

UT Health San Antonio, UTSA collaborate to reduce health disparities, train public health professionals Contact: Will Sansom, UT Health San Antonio, 210-567-2579, sansom@uthscsa.edu Joe Izbrand, UTSA, 210-458-8754, joe.izbrand@utsa.edu SAN ANTONIO (June 9, 2022) — Bexar County Commissioners Court gave preliminary approval June 7 to award $10 million to UT Health San Antonio and The University […]

Photo of Cut-Out Stick Figures Symbolizing Public Health